« Back to Record
Citation APA

Le, D., Kavan, P., Kim, T. Y., Burge, M., Van Cutsem, E., Hara, H., Boland, P., Van Laethem, J.-L., Geva, R., Taniguchi, H., Crocenzi, T., Sharma, M., Atreya, C., Diaz, L. A. L., Liang, L., Marinello, P., Dai, T., & O'Neill, B. (2018). Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability-high (MSI-H) colorectal cancer: KEYNOTE-164. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 29, v107. doi:10.1093/annonc/mdy149.020


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/307496

Le, D., Kavan, P., Kim, T. Y., Burge, M., Van Cutsem, E., Hara, H., Boland, P., Van Laethem, J.-L., Geva, R., Taniguchi, H., Crocenzi, T., Sharma, M., Atreya, C., Diaz, L. A. L., Liang, L., Marinello, P., Dai, T., & O'Neill, B. (2018). Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability-high (MSI-H) colorectal cancer: KEYNOTE-164. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 29, v107. doi:10.1093/annonc/mdy149.020